Issue 41 - The Cancer Letter

Owkin's AI model provides proof of concept that machine learning can predict gene expression across cancer types

Will an oncologist of the not-so-distant future be able to pull up an image of a tumor biopsy slide on a screen and—without having to order a biomarker test—see the molecular characteristics of the cancer?

Racism is a malignancy: Ibram X. Kendi reflects on his cancer experience

Toward a new kind of lung cancer awareness: Addressing financial toxicity

In Brief

AACR 2021 annual meeting will be virtual

C. Ola Landgren named the inaugural leader of experimental therapeutics at Sylvester

Ingo Mellinghoff named chair of MSK Department of Neurology

Beth Gaffney named VP of U.S. and global business development at NCCN

Reagan-Udall receives $250,000 from Rockefeller Foundation for COVID-19 Diagnostics Evidence Accelerator

Global Cancer Institute extends programs for underserved cancer patients to Bangladesh

Clinical Roundup

USPSTF draft guideline: Colorectal cancer screening should start at 45

Study: Racial disparities in treatment NSCLC persist despite gains

Winship study shows increased DFS rates for men with prostate cancer

New York Proton Center joins RadComp clinical trial evaluating proton v. photon therapy in non-metastatic breast cancer

Drugs & Targets

FoundationOne CDx test receives FDA approval as companion diagnostic to identify NTRK fusions in solid tumors for Vitrakvi

FoundationOne Liquid CDx companion diagnostic receives FDA approval in indications for targeted therapies in ovarian, breast and NSCLC

FDA approves cobas EGFR Mutation Test v2 as the first companion diagnostic test for expanded EGFR TKI therapies in NSCLC

CPI-613 receives FDA orphan drug designation for soft tissue sarcoma

Exact Sciences to acquire Thrive Earlier Detection

EQRx licenses two immune checkpoint inhibitors from CStone Pharmaceuticals.

StrataNGS genomic profiling receives Medicare coverage in patients with advanced solid tumors

Recent Issues

Trending Stories

Renew today!

Subscriber content

Login